This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ambit Biosciences Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Shawn R Eichelberger
Introduction
Shawn R Eichelberger is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of proliferative diseases. His work is characterized by a focus on innovative methods and formulations that enhance patient care.
Latest Patents
Shawn R Eichelberger holds 1 patent related to the administration of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or its pharmaceutically acceptable salts or solvates. This patent outlines specific dosing schedules and regimens for human patients, as well as pharmaceutical formulations aimed at treating FLT-3 mediated diseases.
Career Highlights
Eichelberger is associated with Ambit Biosciences Corporation, where he has been instrumental in advancing research and development in the pharmaceutical sector. His expertise in drug formulation and patient administration has positioned him as a valuable asset in his field.
Collaborations
He has collaborated with notable colleagues such as Joyce K James and Traci L Savall, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Shawn R Eichelberger's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to influence the treatment of complex diseases, showcasing the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile